HomeNRXP • NASDAQ
add
NRX Pharmaceuticals Inc
Previous close
$3.05
Day range
$3.03 - $3.19
Year range
$2.21 - $12.00
Market cap
32.72M USD
Avg Volume
232.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.41M | -55.44% |
Net income | -4.33M | 57.70% |
Net profit margin | — | — |
Earnings per share | -0.50 | 68.75% |
EBITDA | -4.40M | 55.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.60M | -77.09% |
Total assets | 7.32M | -71.66% |
Total liabilities | 19.05M | 3.48% |
Total equity | -11.73M | — |
Shares outstanding | 9.45M | — |
Price to book | -2.15 | — |
Return on assets | -107.86% | — |
Return on capital | -1,721.09% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.33M | 57.70% |
Cash from operations | -3.19M | 61.63% |
Cash from investing | 1.00K | 0.00% |
Cash from financing | -1.12M | -111.03% |
Net change in cash | -4.31M | -338.61% |
Free cash flow | -1.48M | 68.96% |
About
Founded
2015
Headquarters
Website
Employees
2